Neurofibromatosis 1: clinical review and exceptions to the rules.
about
Neurofibromatosis type 1: a single center's experience in Korea.Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations.The use of anterolateral bowing of the lower leg in the diagnostic criteria for neurofibromatosis type 1.Bone mineral density in children and adolescents with neurofibromatosis type 1.Posterolateral inter-transverse lumbar fusion in a mouse model.The musculoskeletal phenotype of the RASopathies.Neurogenic tumors of soft tissue.Animal models of scoliosis.Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease).The cognitive profile of preschool-aged children with neurofibromatosis type 1.Clinical and instrumental (magnetic resonance imaging [MRI] and multimodal evoked potentials) follow-up of brain lesions in three young patients with neurofibromatosis 1.Ultrastructural synaptic changes associated with neurofibromatosis type 1: a quantitative analysis of hippocampal region CA1 in a Nf1(+/-) mouse model.Anthropometric characteristics and comorbidities in Japanese patients with neurofibromatosis type 1: a single institutional case-control study.High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1.
P2860
Q34347843-AFC515A0-B428-4EA9-A40E-4ACB4B9D5179Q35540306-4889D665-D2F6-42DF-96EB-6793B978B562Q35627964-CA902383-4DE5-4CF1-8D77-C18E1B4F5A78Q35659149-6EA6B62D-9678-4A5B-BDB2-515DD5B666F7Q36588552-01F4CD8B-8216-4A85-AAF7-483CCBDA4901Q37865455-BBA3196D-18EE-48EE-A901-2057FC99CF46Q37993923-CBDCB02A-5FF3-4067-8D1B-35DD745DEA3DQ38285956-BAC33D7B-1C91-4BDD-949C-E1F95921A59AQ46292236-9DA0CBC1-B5B7-465D-9BAC-8CCB4CA02750Q46949902-4CC8AD00-D697-4832-A60A-6B5DADE7A998Q48343500-743C692F-F04C-4F48-9D54-6BBA74D8E8ADQ50980984-84746D89-DAEE-48CB-A71D-FB8AF8BBA793Q51114860-FCEC4F8E-5563-4ED8-854F-DB13F580EC14Q51926332-59F4ABE4-B2BB-40D6-9431-C6E0C416E427
P2860
Neurofibromatosis 1: clinical review and exceptions to the rules.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Neurofibromatosis 1: clinical review and exceptions to the rules.
@ast
Neurofibromatosis 1: clinical review and exceptions to the rules.
@en
Neurofibromatosis 1: clinical review and exceptions to the rules.
@nl
type
label
Neurofibromatosis 1: clinical review and exceptions to the rules.
@ast
Neurofibromatosis 1: clinical review and exceptions to the rules.
@en
Neurofibromatosis 1: clinical review and exceptions to the rules.
@nl
prefLabel
Neurofibromatosis 1: clinical review and exceptions to the rules.
@ast
Neurofibromatosis 1: clinical review and exceptions to the rules.
@en
Neurofibromatosis 1: clinical review and exceptions to the rules.
@nl
P2860
P1476
Neurofibromatosis 1: clinical review and exceptions to the rules.
@en
P2093
Helen Young
Shelley Hyman
P2860
P304
613-21; discussion 627-9, 646-51
P356
10.1177/088307380201700812
P577
2002-08-01T00:00:00Z